ConductScience.org, home

Paper29985448

Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.

Rodriguez R and 8 others. Hypertens Res, 2018. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats. Papers, record 29985448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29985448

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.
PubMed
Journal
Hypertens Res
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2026-10-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodriguez RRuben
2Moreno MMeagan
3Lee AYAndrew Y
4Godoy-Lugo JAJose A
5Nakano DDaisuke
6Nishiyama AAkira
7Parkes DDavid
8Awayda MSMouhamed S
9Ortiz RMRudy M

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin II Type 1 Receptor BlockersMajor topic
Arterial PressureMajor topic
NatriuresisMajor topic
ObesityMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
Animals
Exenatide
Heart Rate
Rats
Rats, Inbred OLETF
Rats, Long-Evans

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in30111855An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity.https://conductscience.org/library/papers/30111855

Source PubMed

Download CSV of comments and corrections

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117715265Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.Am J Physiol Renal Physiol2007https://conductscience.org/library/papers/17715265PubMed
226803771GLP-1 Agonists and Blood Pressure: A Review of the Evidence.Curr Hypertens Rep2016https://conductscience.org/library/papers/26803771PubMed
324296712Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.Diabetes2014https://conductscience.org/library/papers/24296712PubMed
426447224The physiological role of glucagon-like peptide-1 in the regulation of renal function.Am J Physiol Renal Physiol2016https://conductscience.org/library/papers/26447224PubMed
510332947Influence of centrifugation and hindlimb suspension on testosterone and corticosterone excretion in rats.Aviat Space Environ Med1999https://conductscience.org/library/papers/10332947PubMed
612623970The kidney, hypertension, and obesity.Hypertension2003https://conductscience.org/library/papers/12623970PubMed
715485752Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.Am J Hypertens2004https://conductscience.org/library/papers/15485752PubMed
818786605The incretin system and its role in type 2 diabetes mellitus.Mol Cell Endocrinol2009https://conductscience.org/library/papers/18786605PubMed
926636423Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.Diabetes Obes Metab2016https://conductscience.org/library/papers/26636423PubMed
1021331058Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials.Am J Hypertens2011https://conductscience.org/library/papers/21331058PubMed
1115691618Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.Am J Hypertens2005https://conductscience.org/library/papers/15691618PubMed
1219776173Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells.Am J Physiol Renal Physiol2009https://conductscience.org/library/papers/19776173PubMed
1316980380Effect of ramipril on the incidence of diabetes.N Engl J Med2006https://conductscience.org/library/papers/16980380PubMed
1425677912GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.Diabetes2015https://conductscience.org/library/papers/25677912PubMed
158349321Obesity-induced hypertension. Renal function and systemic hemodynamics.Hypertension1993https://conductscience.org/library/papers/8349321PubMed
1618981327
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
Hypertension2008https://conductscience.org/library/papers/18981327PubMed
173588564Incidence and precursors of hypertension in young adults: the Framingham Offspring Study.Prev Med1987https://conductscience.org/library/papers/3588564PubMed
1817376762Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension.Am J Physiol Renal Physiol2007https://conductscience.org/library/papers/17376762PubMed
1925572181One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study.Endocrine2015https://conductscience.org/library/papers/25572181PubMed
2017878513The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.Pharmacol Rev2007https://conductscience.org/library/papers/17878513PubMed

See all 55 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42709280Effects of heart failure pharmacotherapy on natriuresis and diuresis: A narrative review.Heart Fail Rev2026https://conductscience.org/library/papers/42709280PubMed
41102420Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight.Hypertens Res2025https://conductscience.org/library/papers/41102420PubMed
40891153Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?Eur Heart J2026https://conductscience.org/library/papers/40891153PubMed
38477666Incretin and glucagon receptor polypharmacology in chronic kidney disease.Am J Physiol Endocrinol Metab2024https://conductscience.org/library/papers/38477666PubMed
36398458Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats.Clin Exp Pharmacol Physiol2023https://conductscience.org/library/papers/36398458PubMed
32587574Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32587574PubMed
32384887GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation.Cardiovasc Diabetol2020https://conductscience.org/library/papers/32384887PubMed
30111855An interesting cross-talk between the glucagon-like peptide-1 receptor axis and angiotensin receptor pathway for modulation of renal sodium handling in obesity.Hypertens Res2018https://conductscience.org/library/papers/30111855PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29985448

GET https://conductscience.org/api/papers/v1/29985448/references?page=2